[HTML][HTML] Use of pharmacogenetics to optimize immunosuppressant therapy in kidney-transplanted patients
V Urzì Brancati, C Scarpignato, L Minutoli, G Pallio - Biomedicines, 2022 - mdpi.com
Immunosuppressant drugs (ISDs) are routinely used in clinical practice to maintain organ
transplant survival. However, these drugs are characterized by a restricted therapeutic …
transplant survival. However, these drugs are characterized by a restricted therapeutic …
Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
VU Brancati, C Scarpignato, L Minutoli… - Biomedicines, 2022 - search.proquest.com
Immunosuppressant drugs (ISDs) are routinely used in clinical practice to maintain organ
transplant survival. However, these drugs are characterized by a restricted therapeutic …
transplant survival. However, these drugs are characterized by a restricted therapeutic …
Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
VU Brancati, C Scarpignato, L Minutoli, G Pallio - 2022 - agris.fao.org
Immunosuppressant drugs (ISDs) are routinely used in clinical practice to maintain organ
transplant survival. However, these drugs are characterized by a restricted therapeutic …
transplant survival. However, these drugs are characterized by a restricted therapeutic …
[HTML][HTML] Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
VU Brancati, C Scarpignato, L Minutoli, G Pallio - Biomedicines, 2022 - ncbi.nlm.nih.gov
Immunosuppressant drugs (ISDs) are routinely used in clinical practice to maintain organ
transplant survival. However, these drugs are characterized by a restricted therapeutic …
transplant survival. However, these drugs are characterized by a restricted therapeutic …
Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
VU Brancati, C Scarpignato, L Minutoli… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Immunosuppressant drugs (ISDs) are routinely used in clinical practice to maintain organ
transplant survival. However, these drugs are characterized by a restricted therapeutic …
transplant survival. However, these drugs are characterized by a restricted therapeutic …
Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
V Urzi Brancati, C Scarpignato, L Minutoli, G Pallio - BIOMEDICINES, 2022 - iris.unime.it
Immunosuppressant drugs (ISDs) are routinely used in clinical practice to maintain organ
transplant survival. However, these drugs are characterized by a restricted therapeutic …
transplant survival. However, these drugs are characterized by a restricted therapeutic …
[PDF][PDF] Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients. Biomedicines 2022, 10, 1798
V Urzì Brancati, C Scarpignato, L Minutoli, G Pallio - 2022 - pdfs.semanticscholar.org
Immunosuppressant drugs (ISDs) are routinely used in clinical practice to maintain organ
transplant survival. However, these drugs are characterized by a restricted therapeutic …
transplant survival. However, these drugs are characterized by a restricted therapeutic …
Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients.
V Urzì Brancati, C Scarpignato, L Minutoli… - …, 2022 - search.ebscohost.com
Immunosuppressant drugs (ISDs) are routinely used in clinical practice to maintain organ
transplant survival. However, these drugs are characterized by a restricted therapeutic …
transplant survival. However, these drugs are characterized by a restricted therapeutic …
Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients.
C Scarpignato, L Minutoli, G Pallio - Biomedicines, 2022 - europepmc.org
Immunosuppressant drugs (ISDs) are routinely used in clinical practice to maintain organ
transplant survival. However, these drugs are characterized by a restricted therapeutic …
transplant survival. However, these drugs are characterized by a restricted therapeutic …